Schedule 13G ownership disclosure

ARIAD PHARMACEUTICALS INC

Security class unavailable · CUSIP: 04033A100

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,069,623
Percent of class
4.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001421578-16-000081
Form type
SC 13G/A
Filer
ARIAD PHARMACEUTICALS INC
CIK
CIK 884731
Filed
Sep 12, 2016
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub